[Molecular and epidemiologic aspects of the resistance to antibiotics: example of glycopeptides on enterococci].
The emergence of glycopeptide resistance in enterococci results in a severe clinical problem. Efforts to limit the spread of glycopeptide-resistant enterococci are now considered essential. The many ways in which the resistant strains can disseminate, both in the community and in hospitals, are a source of difficulty in reaching that goal.
Courvalin
P
P
Centre National de la Résistance aux Antibiotiques, Institut Pasteur, Paris, France.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D016983:Enterococcus / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D004813:Epidemiology; D006020:Glycopeptides; D016133:Polymerase Chain Reaction
D000900:Anti-Bacterial Agents; D006020:Glycopeptides
Aspects moléculaires et épidémiologiques de la résistance aux antibiotiques: exemple des glycopeptides chez les entérocoques.